Joshua Liang is a prominent figure in the life sciences industry, with extensive experience in healthcare investment banking and gene expression. He studied B.S. Economics with a concentration in Finance and B.A. Biology in the Roy and Diana Vagelos Program in Life Sciences and Management at the University of Pennsylvania. Liang's passion for the life sciences industry has led him to become the Chief Executive Officer and Board Director at Clover Biopharmaceuticals, after serving as their Former Chief Strategy Officer and Board Director. Prior to working at Clover Biopharmaceuticals, he held positions at Centerview Partners, UBS, Vertex Pharmaceuticals, Global Platinum Securities, and ICBC International.